Green Tea Inhibits Human Inducible Nitric-Oxide Synthase Expression by Down-Regulating Signal Transducer and Activator of Transcription-1α Activation

Molecular Pharmacology

Volumn 65, Issue 1, 2004, Pages 111-120

  Tedeschi, Elisa ^a   Menegazzi, Marta ^a   Yao, Ying ^b   Suzuki, Hisanori ^a   Förstermann, Ulrich ^b   Kleinert, Hartmut ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; STAT1 ALPHA PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DNA BINDING; ENDOTOXEMIA; ENZYME INDUCTION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; TEA; TRANSCRIPTION REGULATION;

CELL SURVIVAL; DNA; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3; NF-KAPPA B; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLANT EXTRACTS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TEA; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 1642454583     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.1.111     Document Type: Article

References (40)

1. Barnes PJ and Liew FY (1995) Nitric oxide and asthmatic inflammation. Immunol Today 16:128-130.
2. Bogdan C (2001) Nitric oxide and the immune response, Nat Immunol 2:907-916.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Cavicchi M and Whittle BJ (1999) Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br J Pharmacol 128:705-715.
5. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Darnell JE Jr, Kerr IM, and Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Wash DC) 264:1415-1421.
7. Das M, Sur P, Gomes A, Vedasiromoni JR and Ganguly DK (2002) Inhibition of tumour growth and inflammation by consumption of tea. Phytother Res 16:S40-S44.
8. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR, and Geller DA (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93:1054-1059.
9. Dell'Albani P, Santangelo R, Torrisi L, Nicoletti VG, de Vellis J, and Giuffrida Stella AM (2001) JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J Neurosci Res 65:417-424.
10. Fujiki H, Suganuma M, Imai K, and Nakachi K (2002) Green tea: cancer preventive beverage and/or drug. Cancer Lett 188:9-13.
11. Ganster RW, Taylor BS, Shao L, and Geller DA (2001) Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 98:8638-8643.
12. Gao J, Morrison DC, Parmely TJ, Russell SW, and Murphy WJ (1997) An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-g and lipopolysaccharide. J Biol Chem 272:1226-1230.
13. Guslandi M (1998) Nitric oxide and inflammatory bowel diseases. Eur J Clin Investig 28:904-907.
14. Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, and Mukhtar H (1999) Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 96:4524-4529.
15. Hausding M, Witteck A, Rodriguez-Pascual F, von Eichel-Streiber M, Förstermann U, and Kleinert H (2000) Inhibition of small G proteins of the Rho family enhances cytokine-mediated induction of NO synthase II. Br J Pharmacol 131:553-561.
16. Husain K (2002) Exercise conditioning attenuates the hypertensive effects of nitric oxide synthase inhibitor in rat. Mol Cell Biochem 231:129-137.
17. Ihle JN (1995) Cytokine receptor signalling. Nature (Lond) 377:591-594.
18. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, and Silvennoinen O (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222-227.
19. Jaiswal M, LaRusso NF and Gores GJ (2001) Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol 281:G626-G634.
20. Kang DG, Hur TY, Lee GM, Oh H, Kwon TO, Sohn EJ, and Lee HS (2002) Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sci 70:2599-2609.
21. Kleinert H, Boissel JP, Schwarz PM, and Förstermann U (2000) Regulation of the expression of nitric oxide synthase isoforms, in Nitric Oxide: Biology and Pathobiology (Ignarro LJ ed) pp 105-128, Academic Press, New York.
22. Kleinert H, Euchenhofer C, Ihrig-Biedert I, and Förstermann U (1996) Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 49:15-21.
23. Kleinert H, Geller DA, and Förstermann U (1999) Analysis of the molecular mechanism regulating the induction of the human NO synthase II promoter in human A549/8 alveolar carcinoma cells. Naunyn-Schmiedeberg's Arch Pharmacol 359: R37.
24. Kleinert H, Wallerath T, Fritz G, Ihrig-Biedert I, Rodriguez-Pascual F, Geller DA, and Förstermann U (1998) Cytokine induction of NO Synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-κB-signaling pathways. Br J Pharmacol 125:193-201.
25. Kröncke KD, Fehsel K, and Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147-156.
26. Leonard N, Bishop AE, Polak JM, and Talbot IC (1998) Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol 51:750-753.
27. Lin JK (2002) Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res (NY) 25:561-571.
28. Lin YL and Lin JK (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 52:465-472.
29. MacMicking J, Xie QW, and Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350.
30. Menegazzi M, Tedeschi E, Dussin D, De Prati AC, Cavalieri E, Mariotto S, and Suzuki H (2001) Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J 15:1309-1311.
31. Ohmori Y and Hamilton TA (2001) Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 69:598-604.
32. Osborne KA, Robichon A, Burgess E, Butland S, Shaw RA, Coulthard A, Pereira HS, Greenspan RJ, and Sokolowski MB (1997) Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. Science (Wash DC) 277:834-836.
33. Shanley TP, Zhao B, Macariola DR, Denenberg A, Salzman AL, and Ward PA (2002) Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med 30:1960-1968.
34. Singh R, Ahmed S, Islam N, Goldberg VM, and Haqqi TM (2002) Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 46:2079-2086.
35. van Straaten EA, Koster-Kamphuis L, Bovee-Oudenhoven IM, van der Meer R, and Forget PP (1999) Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr 88:528-531.
36. Varilek GW, Yang F, Lee EY, de Villiers WJ, Zhong J, Oz HS, Westberry KF, and McClain CJ (2001) Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 131:2034-2039.
37. Wagner BJ, Hayes TE, Hoban CJ, and Cochran BH (1990) The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO (Eur Mol Biol Organ) J 9:4477-4484.
38. Witteck A, Yao Y, Fechir M, Förstermann U, and Kleinert H (2003) Human iNOS gene expression is regulated by Rho protein-mediated changes in the structure of the actin cytoskeleton. Exp Cell Res 287:106-115.
39. Yang CS, Lee MJ, Chen L, and Yang GY (1997) Polyphenols As Inhibitors of Carcinogenesis. Environ Health Perspect 105 (Suppl 4):971-976.
40. Yao Y, Hausding M, Erkel G, Anke T, Forstermann U, and Kleinert H (2003) Sporogen, S14-95 and S-curvularin, three inhibitors of human inducible nitric-oxide synthase expression isolated from fungi. Mol Pharmacol 63:383-391.